MLICM
VCEL icon

Metropolitan Life Insurance Company (MetLife)’s Vericel Corp VCEL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,609
Closed -$136K – 2030
2024
Q1 		$136K Sell
2,609
-290
-10% -$12.7K 0.01% 890
2023
Q4 		$103K Hold
2,899
– – ﹤0.01% 1063
2023
Q3 		$97.2K Buy
2,899
+216
+8% +$7.49K 0.01% 1034
2023
Q2 		$101K Hold
2,683
– – ﹤0.01% 1017
2023
Q1 		$78.7K Sell
2,683
-416
-13% -$12.1K ﹤0.01% 1130
2022
Q4 		$81.6K Hold
3,099
– – ﹤0.01% 1176
2022
Q3 		$71.9K Hold
3,099
– – ﹤0.01% 1214
2022
Q2 		$78K Hold
3,099
– – ﹤0.01% 1213
2022
Q1 		$118K Sell
3,099
-9,717
-76% -$351K ﹤0.01% 1092
2021
Q4 		$504K Hold
12,816
– – 0.01% 1419
2021
Q3 		$625K Hold
12,816
– – 0.01% 1299
2021
Q2 		$673K Buy
12,816
+863
+7% +$49.2K 0.01% 1311
2021
Q1 		$664K Sell
11,953
-2,025
-14% -$91.6K 0.01% 1235
2020
Q4 		$432K Hold
13,978
– – 0.01% 1453
2020
Q3 		$259K Hold
13,978
– – ﹤0.01% 1619
2020
Q2 		$193K Buy
13,978
+1,974
+16% +$26.7K ﹤0.01% 1817
2020
Q1 		$110K Sell
12,004
-4,175
-26% -$62.6K ﹤0.01% 1977
2019
Q4 		$282K Sell
16,179
-837
-5% -$14.2K ﹤0.01% 1681
2019
Q3 		$258K Buy
17,016
+2,925
+21% +$51.2K ﹤0.01% 1706
2019
Q2 		$266K Hold
14,091
– – ﹤0.01% 1701
2019
Q1 		$247K Hold
14,091
– – ﹤0.01% 1762
2018
Q4 		$245K Buy
14,091
+932
+7% +$13.9K ﹤0.01% 1668
2018
Q3 		$186K Hold
13,159
– – ﹤0.01% 2050
2018
Q2 		$128K Buy
+13,159
New +$164K ﹤0.01% 2204

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VCEL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vericel Corp (VCEL) in Q2 2024, closing a stake of 2,609 shares — an estimated $136K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VCEL in Q2 2018 and held it in 24 quarters. The position peaked at $673K in Q2 2021. 261 funds tracked by Wall St. Rank hold VCEL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Vericel Corp position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,609 Vericel Corp shares in Q2 2024, an estimated $136K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Vericel Corp in Q2 2018 and held it in 24 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Vericel Corp position peaked at $673K in Q2 2021.
  • 261 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.